CIK 0001896212
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 873272543
- Phone
- +1 646-491-9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 2 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-23 | Regan Andrew 10% owner | Other acquisition | +499,616 | 499,618 | ||
| 2026-10-22 | Regan Andrew 10% owner | Other acquisition | +1,347,616 | 1,347,619 | ||
| 2026-08-28 | Regan Andrew Chief Executive Officer | Other acquisition | +543,683 | 569,322 | ||
| 2026-08-28 | Regan Andrew Chief Executive Officer | Sale | −29 | 569,322 | ||
| 2026-08-28 | Regan Andrew Chief Executive Officer | Option exercise · Pre-Funded Warrants | −543,683 | $0.00 | $54 | 0 |
| 2026-08-28 | Regan Andrew Chief Executive Officer | Other acquisition | +5,436,830 | 5,693,223 | ||
| 2026-08-28 | Regan Andrew Chief Executive Officer | Sale | −290 | 5,692,933 | ||
| 2026-08-28 | Regan Andrew Chief Executive Officer | Option exercise · Pre-Funded Warrants | −5,436,830 | $0.00 | $544 | 0 |
| 2026-07-30 | Regan Andrew Chief Executive Officer | Other acquisition · Pre-Funded Warrants | +5,436,830 | $0.00 | $544 | 543,683 |
| 2026-07-30 | Regan Andrew Chief Executive Officer | Other acquisition · Pre-Funded Warrants | +5,436,830 | $0.00 | $544 | 5,436,830 |
| 2026-05-13 | Regan Andrew Chief Executive Officer | Grant or award | +100,000 | $1.90 | $190K | 256,393 |
| 2026-03-24 | Regan Andrew Chief Executive Officer | Grant or award | +147,401 | 156,393 | ||
| 2026-03-24 | Regan Andrew Chief Executive Officer | Conversion · Pre-Funded Warrants | −147,401 | $0.00 | $15 | 0 |
| 2025-12-08 | Regan Andrew Chief Executive Officer | Grant or award | +224,800 | $1.79 | $402K | 227,304 |
| 2025-12-08 | Regan Andrew Chief Executive Officer | Grant or award · Pre-Funded Warrants | +3,685,815 | $0.00 | $369 | 3,685,815 |
| 2025-09-19 | Regan Andrew Chief Executive Officer | Grant or award | +1,120,000 | $0.69 | $769K | 1,120,044 |
| 2025-06-03 | Regan Andrew Chief Executive Officer | Grant or award | +154,799 | $3.23 | $500K | 154,799 |
| 2024-07-17 | Regan Andrew Director | Sale | −1,514,100 | $0.26 | $391K | 177,627 |
| 2024-07-16 | Regan Andrew Director | Sale | −10,244,392 | $0.32 | $3.2M | 1,691,727 |
| 2024-07-15 | Regan Andrew Director | Sale | −1,005,200 | $0.25 | $248K | 11,936,119 |
Page 1 of 2 · 29 trades